17th Feb 2021 14:24
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 16 February 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,105,212 | 1.63% | 489,888 | 0.38% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
183,127 | 0.14% | 318,405 | 0.25% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
2,294,339 | 1.78% | 814,293 | 0.63% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 229.1200 USD |
| Purchase | 3 | 228.2900 USD |
| Purchase | 8 | 227.8400 USD |
| Purchase | 8 | 228.5300 USD |
| Purchase | 10 | 228.1520 USD |
| Purchase | 21 | 227.6957 USD |
| Purchase | 24 | 228.4491 USD |
| Purchase | 50 | 227.3800 USD |
| Purchase | 100 | 227.8500 USD |
| Purchase | 100 | 229.3050 USD |
| Purchase | 100 | 227.4600 USD |
| Purchase | 158 | 227.1768 USD |
| Purchase | 217 | 228.1501 USD |
| Purchase | 237 | 228.2919 USD |
| Purchase | 537 | 227.7170 USD |
| Purchase | 719 | 228.4155 USD |
| Purchase | 997 | 227.9844 USD |
| Purchase | 3,236 | 228.2763 USD |
| Purchase | 5,000 | 228.5156 USD |
| Purchase | 7,375 | 228.0141 USD |
| Purchase | 8,808 | 228.2875 USD |
| Purchase | 131,373 | 228.1100 USD |
| Sale | 1 | 227.7200 USD |
| Sale | 4 | 228.4550 USD |
| Sale | 6 | 228.5200 USD |
| Sale | 10 | 228.1520 USD |
| Sale | 10 | 228.0220 USD |
| Sale | 12 | 228.1600 USD |
| Sale | 12 | 228.3850 USD |
| Sale | 12 | 228.3300 USD |
| Sale | 13 | 228.1373 USD |
| Sale | 16 | 228.5700 USD |
| Sale | 18 | 228.2533 USD |
| Sale | 18 | 227.9400 USD |
| Sale | 18 | 228.1283 USD |
| Sale | 22 | 228.6000 USD |
| Sale | 39 | 228.1423 USD |
| Sale | 48 | 228.0487 USD |
| Sale | 69 | 228.0000 USD |
| Sale | 100 | 227.8500 USD |
| Sale | 100 | 227.4600 USD |
| Sale | 100 | 228.6400 USD |
| Sale | 100 | 228.7000 USD |
| Sale | 100 | 228.4500 USD |
| Sale | 106 | 228.3328 USD |
| Sale | 120 | 228.3566 USD |
| Sale | 138 | 228.5300 USD |
| Sale | 237 | 228.2919 USD |
| Sale | 343 | 228.4773 USD |
| Sale | 384 | 228.4536 USD |
| Sale | 418 | 228.5312 USD |
| Sale | 513 | 227.6593 USD |
| Sale | 583 | 228.5156 USD |
| Sale | 883 | 228.0133 USD |
| Sale | 1,029 | 227.9861 USD |
| Sale | 1,438 | 228.4244 USD |
| Sale | 2,234 | 228.5693 USD |
| Sale | 5,143 | 228.3650 USD |
| Sale | 6,658 | 227.9941 USD |
| Sale | 6,695 | 228.2194 USD |
| Sale | 131,337 | 228.1100 USD |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
| SWAP | Long | 1 | 373,634,890.0000 USD |
| SWAP | Long | 1 | 159,717,120.0000 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 17 Feb 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative |
|
|
| |
| relates |
|
|
| |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005623/en/
Copyright Business Wire 2021
Related Shares:
Barclays